Content area
Knowledge-accelerated drug development is a step-by-step process that companies can adopt to take full advantage of state-of-the-art computer-assisted technology. At an operational level within projects, research teams can use knowledge-accelerated drug development to assess different trial designs by accounting for many more variables that affect outcome than traditional methods can accomplish. That allows the team to choose the best design. Moving from current clinical planning methodology to new technology that provides better assessments can occur in 4 sequential steps: 1. computer-based trials management, 2. computer-assisted trial design, 3. computer-assisted clinical program design, and 4. computer-assisted portfolio management.